Skip to main content
NRXP logo

NRXP · NRX Pharmaceuticals, Inc. · Analyst Estimates

Track NRXP — free
$2.54 -0.01 (-0.39%) Play latest call Q3 2026 earnings call transcript
Market Cap
$113.04M
Shares
44.33M
Volume · Nov 19 1.4M Avg daily vol (3M) 1.06M

Analyst Estimates

Compare analyst forecasts for NRX Pharmaceuticals, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-19 16:09 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.80
-0.80
-0.80
1
-0.80
-0.80
-0.36
-0.36
1
1
0
0
Revenue
USD
Publication date not stated
4.49M
4.49M
4.49M
1
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.35
-0.35
-0.35
1
-0.35
-0.35
0.50
0.50
1
1
0
0
Revenue
USD
Publication date not stated
6.00M
77.49M
228.50M
4
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.17
-0.17
-0.17
1
-0.17
-0.17
-0.03
-0.03
1
1
0
0
Revenue
USD
Publication date not stated
1.16M
1.16M
1.16M
1
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.17
-0.17
-0.17
1
-0.17
-0.17
0.00
0.00
1
1
0
0
Revenue
USD
Publication date not stated
1.20M
9.80M
23.20M
3
— — — — — — — —
Key facts CIK 1719406 CUSIP 629444209 13F (30d) 53 filings 49 filers Visit website Investor relations